GENELUX CORP (GNLX:NASDAQ)
$2.94 -0.11 (-3.6066%)
Analysed GENELUX CORP (GNLX:NASDAQ) News Sources
Genelux Corporation Announces Appointment of Jason Litten, M.D., as Chief Medical Officer
02-01-2026
yahoo.com
Genelux Corporation Reports Encouraging Interim Data of Systemic Administration of Olvi-Vec in Ongoing Lung Cancer Trials
05-01-2026
yahoo.com
Genelux Corporation Announces Proposed Public Offering of Common Stock
07-01-2026
yahoo.com
Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock
08-01-2026
yahoo.com
Genelux Corporation Announces Upcoming Virtual Fireside Chat Hosted by Titan Partners
12-01-2026
yahoo.com
Genelux Corporation to Participate in Upcoming Conferences
18-02-2026
yahoo.com
Genelux Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
19-03-2026
yahoo.com
Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates
07-05-2026
yahoo.com
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
30-06-2026
yahoo.com
Attovia Therapeutics Appoints John W. Smither to Board of Directors
15-07-2026
yahoo.com
What is the current price of GENELUX CORP (GNLX:NASDAQ)?
The current price of GENELUX CORP (GNLX:NASDAQ) is $2.94.
GENELUX CORP (GNLX:NASDAQ) absolute price change since previous trading day?
The absolute price change of GENELUX CORP (GNLX:NASDAQ) since the previous trading day is $-0.11.
GENELUX CORP (GNLX:NASDAQ) percentage price change since previous trading day?
The percentage price change of GENELUX CORP (GNLX:NASDAQ) since the previous trading day is -3.6066%.
What is the most recent average sentiment score for GENELUX CORP (GNLX:NASDAQ)?
The most recent average sentiment score for GENELUX CORP (GNLX:NASDAQ) is 67 out of 100.
What is the most recent average sentiment for GENELUX CORP (GNLX:NASDAQ)?
The most recent sentiment for GENELUX CORP (GNLX:NASDAQ) is .
SEC-8K** Filing Available For GENELUX CORP (GNLX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.